The case for colorectal cancer screening

Area of Science:

• Gastroenterology
• Oncology
• Preventive Medicine

Background:

• Colorectal cancer (CRC) remains a significant public health concern.
• Effective screening strategies are crucial for early detection and mortality reduction.
• Current screening modalities have varying degrees of efficacy and evidence support.

Purpose of the Study:

• To evaluate the effectiveness of sigmoidoscopic screening in reducing colorectal cancer mortality.
• To assess the evidence supporting fecal occult blood testing for CRC screening.
• To determine the optimal screening interval and age range for flexible sigmoidoscopy.

Main Methods:

• Review of existing evidence on sigmoidoscopic screening efficacy.
• Analysis of data regarding colorectal cancer mortality reduction associated with screening.
• Evaluation of the evidence base for fecal occult blood testing.

Main Results:

• Strong evidence indicates sigmoidoscopic screening can decrease colorectal cancer mortality by up to 70%.
• The evidence supporting extensive fecal occult blood testing is less conclusive.
• Flexible sigmoidoscopy every 5-10 years for individuals aged 50-75 is considered warranted.

Conclusions:

• Flexible sigmoidoscopy is a highly effective tool for reducing colorectal cancer mortality.
• Widespread implementation of sigmoidoscopic screening faces practical barriers that require addressing.
• Further research and policy development are needed to overcome these barriers and promote screening adoption.